Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Filings indexed 572 across all filing types
Latest filing 2022-02-16 Interim / Quarterly Rep…
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS: Results for the fourth quarter 2021
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly report for SoftOx Solutions AS for the 4th quarter of 2021. It contains detailed financial tables (Key figures), operational updates, management commentary (CEO statement), and research/product development progress. It is not an announcement of a report (RPA) nor a simple earnings release (ER), as it provides substantive financial data and analysis for the period. Therefore, it is classified as an Interim/Quarterly Report. Q4 2021
2022-02-16 English
SoftOx Solutions AS: Results for the fourth quarter 2021
Report Publication Announcement Classification · 98% confidence The document explicitly states 'SoftOx Solutions AS: Results for the fourth quarter 2021' and mentions that the 'fourth quarter 2021 report will be available at [link] and attached.' It also announces a webcast presentation for these results. Since the document is very short (1031 chars) and primarily serves to announce the availability of the full report and an associated event (webcast), it fits the definition of a Report Publication Announcement (RPA) rather than the full report itself (which would likely be classified as IR if comprehensive).
2022-02-16 English
SoftOx Solutions AS: Postponed webcast presentation of Q4 2021 results
Report Publication Announcement Classification · 95% confidence The document is a short announcement regarding the postponement of a webcast presentation for Q4 2021 results and provides the new date for the webcast. It explicitly states that the Q4 2021 results will be made available on specific websites on February 16, 2022. Since the document itself is an announcement about the timing/publication of results/presentation rather than the full results (ER) or the presentation itself (IP), and it is very short (1286 chars), it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces the publication of results and the scheduling of the associated presentation, RPA is the most precise fit, as it relates to the publication schedule of company reports/events.
2022-02-15 English
SoftOx Solutions AS: Invitation to the presentation of the 4Q 2021 results
Report Publication Announcement Classification · 95% confidence The document is an invitation to a presentation regarding the 4Q 2021 results, scheduled for February 16th, 2022. It provides the date, time, and RSVP details for the webcast presentation by management. This is not the actual results announcement (ER) or the full report (IR/10-K), but rather an announcement about the upcoming presentation of those results. Since the document is short and serves to announce the timing of a future report/presentation, it fits best under Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2022-02-08 English
SoftOx Solutions AS: Beholder desinfeksjon for hånd og overflate i markedet
Legal Proceedings Report Classification · 99% confidence The document discusses a dispute between SoftOx Solutions AS and the Norwegian Environmental Agency (Miljødirektoratet) regarding the interpretation of the EU Biocidal Products Regulation concerning the sale of their hand and surface disinfectant product in the Norwegian market. The company states its intention to continue selling the product based on the EU Commission's interpretation until formally ordered otherwise, and mentions pursuing clarification through the Ministry of Climate and Environment and potentially legal action. This content details a significant regulatory/legal conflict impacting the company's operations and market access, which aligns best with the 'Legal Proceedings Report' (LTR) category, as it details an ongoing regulatory dispute that may lead to litigation. It is not a standard financial report (10-K, IR, ER) or a general announcement (RNS), but a specific update on a legal/regulatory challenge.
2022-01-31 Norwegian
SoftOx Solutions AS: Mottatt svar fra Miljødirektoratet
Legal Proceedings Report Classification · 99% confidence The document is a short announcement from SoftOx Solutions AS regarding receiving a letter from the Norwegian Environmental Agency (Miljødirektoratet) concerning the interpretation of the European Biocidal Products Regulation. It discusses a regulatory disagreement and potential next steps. Since the text is short (1780 chars) and details a specific regulatory/legal development (disagreement with a government body over product approval/regulation), it fits best under 'Legal Proceedings Report' (LTR) or potentially 'Regulatory Filings' (RNS). Given the specific nature of the dispute concerning regulatory interpretation and potential legal/administrative action, LTR is a strong candidate. However, since it is a direct communication about a regulatory decision/dispute rather than a formal legal filing or lawsuit update, and it is a general regulatory announcement, RNS (Regulatory Filings) serves as a robust fallback for specific regulatory communications that don't fit other categories like ER, IR, or DIV. Given the context of a dispute with a regulatory body, LTR is more specific than RNS, but RNS is often used for general regulatory news. Since the content is about a regulatory body's decision impacting operations, and it is not a formal legal proceeding document, RNS is the most appropriate general regulatory category if LTR is reserved strictly for lawsuits. Given the options, RNS is the safest general regulatory announcement category for this type of official correspondence update.
2022-01-28 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.